Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

9.07
Delayed Data
As of Jul 29
 -0.295 / -3.15%
Today’s Change
4.74
Today|||52-Week Range
11.71
+3.48%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues133.6M156.3M127.1M134.8M
 
 
 
 
 
Cost of Goods Sold19.5M22.0M17.7M23.0M
 
 
 
 
 
Depreciation And Amortization2.9M3.4M860.0K852.0K
 
 
 
 
 
 
Operating ExpensesGross Income111.2M130.8M108.5M110.9M
 
 
 
 
 
General Expenses81.4M92.2M94.9M85.0M
 
 
 
 
 
Other Operating Expenses0.003.8M0.000.00
 
 
Research And Development12.3M4.3M6.6M13.7M
 
 
 
 
 
Total Operating Expenses103.9M121.5M113.4M108.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income29.7M34.8M13.6M26.0M
 
 
 
 
 
Extraordinary Credit3.5M15.4M600.0K0.00
 
 
 
 
Extraordinary Charge-3.8M-43.8M-1.2M--
 
 
 
 
Interest Expense On Debt213.0K185.0K103.0K--
 
 
 
 
Other Expenses-21.0K-42.0K195.0K232.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income29.3M6.3M13.2M26.4M
 
 
 
 
 
Income Taxes-798.0K-3.3M-2.2M-1.2M
 
 
 
 
 
Net Income28.5M9.6M11.0M25.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS55.1M56.6M53.6M51.3M
 
 
 
 
 
Shares To Calculate EPS Diluted57.4M58.5M54.9M52.7M
 
 
 
 
 
 
Earnings Per ShareEPS$0.50$0.16$0.20$0.48
 
 
 
 
 
EPS Diluted$0.50$0.16$0.20$0.48